Related references
Note: Only part of the references are listed.A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways
Qian Dong et al.
CANCER LETTERS (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer
Patricia Fernandez-Nogueira et al.
CANCER LETTERS (2018)
Activation of FOXO3a reverses 5-Fluorouracil resistance in human breast cancer cells
Ying Song et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2018)
Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1
Ruoming Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy
Jin-Fei Chen et al.
MOLECULAR CANCER (2018)
CHP2 Promotes Cell Proliferation in Breast Cancer via Suppression of FOXO3a
Xiaohui Zhao et al.
MOLECULAR CANCER RESEARCH (2018)
LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer
Liyun Luo et al.
ONCOGENE (2018)
Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
Linda Xiaoyan Li et al.
CELL DEATH & DISEASE (2018)
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial
Melanie Royce et al.
JAMA ONCOLOGY (2018)
被撤回的出版物: Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation (Retracted article. See vol. 42, 2023)
Huaying Dong et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway
Liguo Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells
Victoria J. Gennaro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LncRNA MIR100HG promotes cell proliferation in triple- negative breast cancer through triplex formation with p27 loci
Shaowei Wang et al.
CELL DEATH & DISEASE (2018)
Long Non-coding RNA Structure and Function: Is There a Link?
Anna Zampetaki et al.
FRONTIERS IN PHYSIOLOGY (2018)
Cyclin G2 suppresses Wnt/beta-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1
Jinlan Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Role of Long Noncoding RNA 799 in the Metastasis of Cervical Cancer through Upregulation of TBL1XR1 Expression
Ling-Min Liao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1
Erbao Zhang et al.
GENOME BIOLOGY (2018)
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Jose Baselga et al.
LANCET ONCOLOGY (2017)
Treating cancer with selective CDK4/6 inhibitors
Ben O'Leary et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus
Kouhei Sakurai et al.
MOLECULAR CANCER RESEARCH (2015)
Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase
Xingnan Zheng et al.
GENES & DEVELOPMENT (2014)
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth
Franco Izzo et al.
BREAST CANCER RESEARCH (2014)
The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness
Diego Sisci et al.
CELL CYCLE (2013)
1p36 Tumor Suppression-A Matter of Dosage?
Kai-Oliver Henrich et al.
CANCER RESEARCH (2012)
Lin-28 Homologue A (LIN28A) Promotes Cell Cycle Progression via Regulation of Cyclin-dependent Kinase 2 (CDK2), Cyclin D1 (CCND1), and Cell Division Cycle 25 Homolog A (CDC25A) Expression in Cancer
Ning Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Deletion or Epigenetic Silencing of AJAP1 on 1p36 in Glioblastoma
Ningjing Lin et al.
MOLECULAR CANCER RESEARCH (2012)
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
C. T. Karadedou et al.
ONCOGENE (2012)
Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer
Xiao Wu et al.
BREAST CANCER RESEARCH (2012)
CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells
Kai-Oliver Henrich et al.
CANCER RESEARCH (2011)
CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression
Z. Liu et al.
CELL DEATH AND DIFFERENTIATION (2011)
Deletion of the PER3 Gene on Chromosome 1p36 in Recurrent ER-Positive Breast Cancer
Joan Climent et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers
Hongxing Zhang et al.
NATURE GENETICS (2010)
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
C. Welch et al.
ONCOGENE (2007)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
